Search

everythinglearnresearchcommunity

for

Search:↓

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Alopecia areata can regrow hair in a pattern similar to androgenetic alopecia.

PRP treatment effectively reduces hair loss after COVID-19.

Vertex pattern hair loss linked to higher prostate cancer risk.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

There's a significant link between the severity of Seborrheic Dermatitis and the pattern of hair loss in people with a family history of hair loss.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Men with certain patterns of hair loss, especially the U pattern, are more likely to develop insulin resistance.

No significant link between male pattern baldness and COVID-19 severity was found.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Lasers and energy-assisted methods show promise for treating hair loss, but more research is needed.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

PRP injections increased hair density in men with hair loss but didn't work for everyone and more research is needed.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Hair loss linked to heart disease in young men.

Apoptosis contributes to hair loss in androgenetic alopecia.

Higher sebum levels are linked to more severe male baldness.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.